EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequence-specific targeting of GC-rich gene loci by parallel triplex-forming oligonucleotides containing a modified nucleobase

Ruolin Ma, Michael Brazzill, Dylan Justice, Nicholas Buckham, Cen Chen iD, Shuichi Hoshika, Steven A Benner, David A Rusling iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkag998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Ruolin Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, United Kingdom. Hauptthemen laut MEDLINE: GC Rich Sequence, DNA, Oligonucleotides, Genetic Loci. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Medical Sciences, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting GC-rich gene loci is a major challenge owing to their high duplex stability, repetitive sequence composition, and propensity to adopt alternative DNA structures. Triplex-forming oligonucleotides (TFOs) provide a programmable strategy toward the recognition of GC-rich DNA, but their application is restricted by the limited recognition capabilities of natural nucleobases in a cellular setting. Here, we overcome this barrier using parallel-binding TFOs containing the synthetic nucleobase 6-amino-5-nitropyridin-2-one (Z), which enables pH-independent recognition of G-C base pairs. Using two structurally distinct regulatory elements within the MYC promoter, we show that Z-modified TFOs form stable, sequence-selective triplexes that repress promoter activity by 50%–80% in both episomal reporter assays and at endogenous gene loci. Notably, the greatest repression was observed at a GC-rich quadruplex-forming element that functions as a structural hub for transcription factor recruitment. To our knowledge, this represents the first demonstration that a simple nucleobase modification alone is sufficient to enable parallel-binding TFOs to repress expression of an endogenous gene, establishing a general strategy for targeting GC-rich regulatory elements through programmable DNA recognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GC Rich SequenceDNAOligonucleotidesGenetic LociPyridinesPromoter Regions, GeneticHumansGenes, myc

Substanzen

triplex DNADNAOligonucleotidesPyridines

Autor:innen und Institutionen

  • School of Medicine, Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, United Kingdom.
  • Foundation for Applied Molecular Evolution, Alachua, FL 32615, United States.
  • Firebird Biomolecular Sciences LLC, Alachua, FL 32615, United States.

ORCID-Profile: Cen Chen, David A Rusling

Förderung

  • Academy of Medical Sciences
  • NIAID NIH HHS
  • NIH HHS
  • U.S. National Science Foundation
  • University of Portsmouth
  • National Institutes of Health

Zitieren

APA

Ma, R., Brazzill, M., Justice, D., Buckham, N., Chen, C., Hoshika, S., Benner, S. A., & Rusling, D. A. (2026). Sequence-specific targeting of GC-rich gene loci by parallel triplex-forming oligonucleotides containing a modified nucleobase. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag998

Vancouver

Ma R, Brazzill M, Justice D, Buckham N, Chen C, Hoshika S, et al. Sequence-specific targeting of GC-rich gene loci by parallel triplex-forming oligonucleotides containing a modified nucleobase. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag998

BibTeX
@article{Ma2026,
  author = {Ma, Ruolin and Brazzill, Michael and Justice, Dylan and Buckham, Nicholas and Chen, Cen and Hoshika, Shuichi and Benner, Steven A and Rusling, David A},
  title = {Sequence-specific targeting of GC-rich gene loci by parallel triplex-forming oligonucleotides containing a modified nucleobase},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag998}
}
Kostenlos starten →